Crude and age-adjusted and sex-adjusted incidence rates of amyloidosis, in women
| Year | Population* | SpA cohort | Non-SpA cohort | ||||||||
| Cases | Crude rate (/100,000/year) | Adjusted rate† (/100,000/year) | 95% CI | Cases | Crude rate (/100,000/year) | Adjusted rate† (/100,000/year) | 95% CI | ||||
| 1999 | 88 345 | 9 | 10.19 | 10.83 | 4.88 | 21.50 | 1 | 1.13 | 1.11 | 0.05 | 7.84 |
| 2000 | 89 269 | 16 | 17.92 | 17.96 | 10.17 | 30.15 | 2 | 2.24 | 2.45 | 0.27 | 9.97 |
| 2001 | 90 155 | 8 | 8.87 | 9.00 | 3.86 | 18.73 | 0.00 | 0.00 | – | – | |
| 2002 | 91 775 | 22 | 23.97 | 24.56 | 15.33 | 38.01 | 1 | 1.09 | 1.57 | 0.05 | 8.75 |
| 2003 | 93 561 | 8 | 8.55 | 9.79 | 4.19 | 19.84 | 0.00 | 0.00 | – | – | |
| 2004 | 95 092 | 10 | 10.52 | 10.78 | 5.13 | 20.49 | 2 | 2.10 | 2.28 | 0.28 | 9.02 |
| 2005 | 96 792 | 9 | 9.30 | 9.44 | 4.31 | 18.59 | 1 | 1.03 | 1.06 | 0.05 | 6.88 |
| 2006 | 98 323 | 10 | 10.17 | 10.66 | 5.07 | 20.11 | 1 | 1.02 | 1.05 | 0.05 | 6.66 |
| 2007 | 100 146 | 11 | 10.98 | 11.89 | 5.91 | 21.61 | 2 | 2.00 | 2.15 | 0.27 | 8.29 |
| 2008 | 101 634 | 4 | 3.94 | 4.35 | 1.16 | 11.44 | 2 | 1.97 | 2.05 | 0.26 | 7.93 |
| 2009 | 102 511 | 15 | 14.63 | 15.39 | 8.61 | 25.68 | 1 | 0.98 | 1.01 | 0.05 | 6.11 |
| 2010 | 103 062 | 21 | 20.38 | 21.07 | 13.01 | 32.44 | 1 | 0.97 | 1.13 | 0.05 | 6.32 |
| 2011 | 103 546 | 15 | 14.49 | 14.86 | 8.31 | 24.67 | 2 | 1.93 | 2.05 | 0.26 | 7.55 |
| 2012 | 103 773 | 4 | 3.85 | 3.98 | 1.06 | 10.33 | 0.00 | 0.00 | – | – | |
| 2013 | 103 610 | 12 | 11.58 | 11.85 | 6.10 | 20.74 | 5 | 4.83 | 4.94 | 1.59 | 11.59 |
| 2014 | 103 443 | 18 | 17.40 | 17.57 | 10.39 | 27.77 | 5 | 4.83 | 4.86 | 1.56 | 11.36 |
| 2015 | 103 411 | 4 | 3.87 | 3.87 | 1.03 | 9.89 | 2 | 1.93 | 1.93 | 0.26 | 6.99 |
| 1999–2015 | 1 668 447 | 196 | 11.75 | 12.23 | 28 | 1.68 | 1.74 | ||||
*Población estimada de SpA.22
†Adjusted by sex and age.
SpA, spondyloarthritis.